Pharmaceutical use of hexahydro-dibenzo[a,g]quinolizine compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9737517
APP PUB NO 20160193195A1
SERIAL NO

14888797

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Use of hexahydro-dibenzo[a,g]quinolizine compounds as shown in formula(I) in preparing a medicine for treating and/or preventing benign prostate hyperplasia diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES201203 555 ZHANGJIANG ROAD ZHANGJIANG PUDONG NEW AREA SHANGHAI SHANGHAI CITY SHANGHAI CITY 201203

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Kaixian Shanghai, CN 52 28
Chen, Ying Shanghai, CN 944 21963
Jiang, Hualiang Shanghai, CN 58 37
Li, Jing Shanghai, CN 1112 6098
Li, Zeng Shanghai, CN 45 154
Liu, Hong Shanghai, CN 550 3045
Sun, Haifeng Shanghai, CN 17 81
Xie, Xin Shanghai, CN 72 155
Zhao, Fei Shanghai, CN 117 596
Zhou, Yu Shanghai, CN 454 2834

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 22, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00